Current Clinical Trial Programs
Acute Treatment of MigrainePRESTO: A prospective, multi-center, randomized, double-blind, sham-controlled study of gammaCore®, a non-invasive vagus nerve stimulation device (nVNS) for the acute treatment of migraine attacks.
Prevention of MigrainePREMIUM: A multi-center, randomized, double-blind, parallel, sham-controlled study of gammaCore®, a non-invasive vagus nerve stimulation device (nVNS) for the prevention of episodic migraine.
The best way to access current information about the status of our US clinical trials is by visiting the NIH’s clinical trials website www.clinicaltrials.gov. You may use the keywords “electroCore” or “gammaCore” to look up information about our studies.
To access the complete results of electroCore’s clinical trial program to date, please visit www.ecorelibrary.com..